Table 1.
Patients’ baseline characteristics.
| Variable | |
|---|---|
| Age, years | 66 ± 10 |
| Men | 41 (79) |
| Smoking history | |
| Current | 6 (11.5) |
| Ex-smoker | 17 (32.7) |
| None | 29 (55.8) |
| Packs per year | 31 ± 3 |
| FVC, % pred. | 78.9 ± 10.5 |
| FEV1, % pred. | 84.05 ± 12.51 |
| FEV1/FVC | 81 ± 6.1 |
| Mean duration between each visit, days | 105.1 ± 100.5 |
| Nintedanib | 7 (13.7) |
| Pirfenidone | 40 (78.4) |
| Non-antifibrotic treatment | 4 (7.8) |
| Comorbidities | 24 (46) |
| Prednisone | 13 (25) |
| LTOT | 28 (53.8) |
| Antibiotics | 8 (15.3) |
| Inhaled therapy | 13 (25) |
| Anticoagulation | 9 (17.3) |
*Values are expressed as mean ± standard deviation or number (percentage).
*Any treatment was taken into account from the moment of inclusion.
FVC, forced vital capacity; FEV1, forced expiratory volume in the first second; LTOT, long-term oxygen therapy; pred., predicted.